Tumor suppressor WWOX and p53 alterations and drug resistance in glioblastomas

Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptotic protein and is considered as a tumor suppressor. Loss of WWOX gene exp...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Ming-Fu eChiang, Pei-Yi eChou, Wan-Jen eWang, Chun-I eSze, Nan-Shan eChang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2013-03-01
Sarja:Frontiers in Oncology
Aiheet:
p53
tumor suppressor
Glioblastoma Multiforme
WWOX
temozolomide resistance
Linkit:http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00043/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia